Table 2.
Height z-scoreab |
SSM |
Melanoma NOS |
NM |
LMM |
|
---|---|---|---|---|---|
7 years |
13 years |
HR (95% CI) |
HR (95% CI) |
HR (95% CI) |
HR (95% CI) |
0 | 0 | Reference | Reference | Reference | Reference |
0.5 | 0 | 1.07 (1.01–1.14) | 1.12 (1.03–1.22) | 1.05 (0.90–1.23) | 1.08 (0.79–1.46) |
0 | 0.5 | 1.03 (0.97–1.09) | 0.98 (0.90–1.07) | 1.06 (0.91–1.23) | 1.04 (0.77–1.41) |
0.5 | 0.5 | 1.10 (1.07–1.14) | 1.10 (1.05–1.15) | 1.11 (1.03–1.20) | 1.12 (0.95–1.31) |
Abbreviations: CI, confidence interval; HR, hazard ratio; LMM, lentigo maligna melanoma; NM, nodular melanoma; NOS, not otherwise specified; SSM, superficial spreading melanoma.
All analyses were stratified by sex and 5-year birth cohorts.
The reference child has a height z-score of 0, a ‘taller’ child has a z-score of 0.5, and a ‘persistently taller’ child has a z-score of 0.5 at both age 7 years and 13 years.